IL83572A - Nasal pharmaceutical compositions comprising octreotide - Google Patents

Nasal pharmaceutical compositions comprising octreotide

Info

Publication number
IL83572A
IL83572A IL83572A IL8357287A IL83572A IL 83572 A IL83572 A IL 83572A IL 83572 A IL83572 A IL 83572A IL 8357287 A IL8357287 A IL 8357287A IL 83572 A IL83572 A IL 83572A
Authority
IL
Israel
Prior art keywords
octreotide
pharmaceutical compositions
nasal pharmaceutical
nasal
compositions
Prior art date
Application number
IL83572A
Other languages
English (en)
Other versions
IL83572A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620035A external-priority patent/GB8620035D0/en
Priority claimed from GB868626821A external-priority patent/GB8626821D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL83572A0 publication Critical patent/IL83572A0/xx
Publication of IL83572A publication Critical patent/IL83572A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL83572A 1986-08-18 1987-08-17 Nasal pharmaceutical compositions comprising octreotide IL83572A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868620035A GB8620035D0 (en) 1986-08-18 1986-08-18 Organic compounds
GB868626821A GB8626821D0 (en) 1986-11-10 1986-11-10 Organic compounds

Publications (2)

Publication Number Publication Date
IL83572A0 IL83572A0 (en) 1988-01-31
IL83572A true IL83572A (en) 1992-09-06

Family

ID=26291187

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83572A IL83572A (en) 1986-08-18 1987-08-17 Nasal pharmaceutical compositions comprising octreotide

Country Status (24)

Country Link
KR (1) KR880002537A (cs)
AT (1) AT396331B (cs)
AU (2) AU612589B2 (cs)
BE (1) BE1001748A4 (cs)
CA (1) CA1322331C (cs)
CH (1) CH672252A5 (cs)
CS (1) CS411491A3 (cs)
DE (1) DE3726517A1 (cs)
DK (1) DK428287A (cs)
ES (1) ES2004807A6 (cs)
FI (1) FI93307C (cs)
FR (1) FR2602680B1 (cs)
GR (1) GR871289B (cs)
HK (1) HK80493A (cs)
HU (1) HU200940B (cs)
IE (1) IE60761B1 (cs)
IL (1) IL83572A (cs)
IT (1) IT1222510B (cs)
LU (1) LU86971A1 (cs)
NL (1) NL8701874A (cs)
NO (1) NO175519C (cs)
NZ (1) NZ221473A (cs)
PT (1) PT85545B (cs)
SE (1) SE8703183L (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003216084A1 (en) 2002-01-22 2003-09-02 New York University Methods for therapeutic treatment of benign prostatic hypertrophy (bph)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4505897A (en) * 1983-04-18 1985-03-19 The Administrators Of The Tulane Educational Fund Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体

Also Published As

Publication number Publication date
DK428287D0 (da) 1987-08-17
CA1322331C (en) 1993-09-21
ES2004807A6 (es) 1989-02-01
FR2602680A1 (fr) 1988-02-19
CS411491A3 (en) 1992-06-17
PT85545B (pt) 1990-05-31
FI873548A0 (fi) 1987-08-17
GR871289B (en) 1987-12-18
SE8703183L (sv) 1988-02-19
HUT46235A (en) 1988-10-28
FI93307B (fi) 1994-12-15
IT8721670A0 (it) 1987-08-18
HU200940B (en) 1990-09-28
FI93307C (fi) 1995-03-27
NZ221473A (en) 1990-08-28
NO873452L (no) 1988-02-19
DE3726517A1 (de) 1988-03-03
IE60761B1 (en) 1994-08-10
LU86971A1 (fr) 1988-03-02
AT396331B (de) 1993-08-25
FR2602680B1 (fr) 1993-04-16
SE8703183D0 (sv) 1987-08-17
AU7712087A (en) 1988-02-25
NL8701874A (nl) 1988-03-16
HK80493A (en) 1993-08-13
AU637530B2 (en) 1993-05-27
KR880002537A (ko) 1988-05-09
AU612589B2 (en) 1991-07-18
PT85545A (en) 1987-09-01
IT1222510B (it) 1990-09-05
BE1001748A4 (fr) 1990-02-27
FI873548L (fi) 1988-02-19
IE872187L (en) 1988-02-18
NO175519B (no) 1994-07-18
NO873452D0 (no) 1987-08-17
NO175519C (no) 1994-10-26
ATA206087A (de) 1992-12-15
CH672252A5 (cs) 1989-11-15
AU8568991A (en) 1991-12-05
DK428287A (da) 1988-02-19
IL83572A0 (en) 1988-01-31

Similar Documents

Publication Publication Date Title
GB2196964B (en) Pharmaceutical compositions
GB8716301D0 (en) Pharmaceutical compositions
GB8717582D0 (en) Pharmaceutical compositions
GB8723121D0 (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8618847D0 (en) Pharmaceutical formulations
GB8608818D0 (en) Pharmaceutical compositions
GR861422B (en) Nasal pharmaceutical compositions
GB8717581D0 (en) Pharmaceutical compositions
GB2191696B (en) Pharmaceutical compositions
GB8618259D0 (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
GB8629781D0 (en) Pharmaceutical compositions
GB8723120D0 (en) Pharmaceutical compositions
GB8723118D0 (en) Pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
GB8719387D0 (en) Pharmaceutical compositions
IL83572A (en) Nasal pharmaceutical compositions comprising octreotide
GR871915B (en) Pharmaceutical formulations
GB8615041D0 (en) Pharmaceutical compositions
IE861461L (en) Nasal pharmaceutical composition
IE862216L (en) Pharmaceutical compositions comprising acylated¹phospholipids
ZA876959B (en) Pharmaceutical formulations
GB8603097D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
RH Patent void